| Sample | Title | Value | Rank |
|---|
| GSM16943 | Wild Type Control Set A | 2.2 | 7 |
| GSM18491 | WT Control Sample B | 2.7 | 12 |
| GSM18492 | MDA-MB-231 Breast Cancer Cells Stably Expressing wild-type ERa 1 Hr Treatment Sample A | 7.1 | 20 |
| GSM18493 | MDA-MB-231 Breast Cancer Cells Stably Expressing wild-type ERa 1 Hr Treatment Sample B | 4.9 | 17 |
| GSM18494 | MDA-MB-231 Breast Cancer Cells Stably Expressing wild-type ERa 2 Hr Treatment Sample A | 3.7 | 10 |
| GSM18495 | MDA-MB-231 Breast Cancer Cells Stably Expressing wild-type ERa 2 Hr Treatment Sample B | 19.9 | 40 |
| GSM18496 | MDA-MB-231 Breast Cancer Cells Stably Expressing Mutant ERa LQ Control Sample A | 4.7 | 13 |
| GSM18497 | MDA-MB-231 Breast Cancer Cells Stably Expressing mutant ERa LQ Sample B | 3.2 | 15 |
| GSM18498 | MDA-MB-231 Breast Cancer Cells Stably Expressing mutant ERa LQ 1 Hr Treatment of 10 nM E2 Sample A | 5 | 11 |
| GSM18499 | MDA-MB-231 Breast Cancer Cells Stably Expressing mutant ERa LQ 1 Hr Treatment of 10 nM E2 Sample B | 5.1 | 18 |
| GSM18500 | MDA-MB-231 Breast Cancer Cells Stably Expressing mutant ERa LQ 2 Hr Treatment of 10 nM E2 Sample A | 21.9 | 34 |
| GSM18501 | MDA-MB-231 Breast Cancer Cells Stably Expressing mutant ERa LQ 2 Hr Treatment of 10 nM E2 Sample B | 13.5 | 32 |